BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35853101)

  • 1. A peptide interfering with the dimerization of oncogenic KITENIN protein and its stability suppresses colorectal tumour progression.
    Kim SJ; Sun EG; Bae JA; Park S; Hong CS; Park ZY; Kim H; Kim KK
    Clin Transl Med; 2022 Jul; 12(7):e871. PubMed ID: 35853101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer.
    Lee JH; Park SR; Chay KO; Seo YW; Kook H; Ahn KY; Kim YJ; Kim KK
    Cancer Res; 2004 Jun; 64(12):4235-43. PubMed ID: 15205336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new KSRP-binding compound suppresses distant metastasis of colorectal cancer by targeting the oncogenic KITENIN complex.
    Bae JA; Bae WK; Kim SJ; Ko YS; Kim KY; Park SY; Yu YH; Kim EA; Chung IJ; Kim H; Ha HH; Kim KK
    Mol Cancer; 2021 May; 20(1):78. PubMed ID: 34039363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer.
    Oh HH; Park KJ; Kim N; Park SY; Park YL; Oak CY; Myung DS; Cho SB; Lee WS; Kim KK; Joo YE
    Oncol Rep; 2016 Jan; 35(1):253-60. PubMed ID: 26496979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KITENIN-targeting microRNA-124 suppresses colorectal cancer cell motility and tumorigenesis.
    Park SY; Kim H; Yoon S; Bae JA; Choi SY; Jung YD; Kim KK
    Mol Ther; 2014 Sep; 22(9):1653-64. PubMed ID: 24909917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unconventional KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-Jun and the invasiveness of colorectal cancer cells.
    Bae JA; Yoon S; Park SY; Lee JH; Hwang JE; Kim H; Seo YW; Cha YJ; Hong SP; Kim H; Chung IJ; Kim KK
    Clin Cancer Res; 2014 Aug; 20(15):4115-28. PubMed ID: 24893630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KITENIN functions as a fine regulator of ErbB4 expression level in colorectal cancer via protection of ErbB4 from E3-ligase Nrdp1-mediated degradation.
    Sun EG; Lee KH; Ko YS; Choi HJ; Yang JI; Lee JH; Chung IJ; Paek YW; Kim H; Bae JA; Kim KK
    Mol Carcinog; 2017 Mar; 56(3):1068-1081. PubMed ID: 27648936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of KITENIN in human colorectal cancer and its relation to tumor behavior and progression.
    Lee S; Song YA; Park YL; Cho SB; Lee WS; Lee JH; Chung IJ; Kim KK; Rew JS; Joo YE
    Pathol Int; 2011 Apr; 61(4):210-20. PubMed ID: 21418393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous KITENIN shRNA injection suppresses hepatic metastasis and recurrence of colon cancer in an orthotopic mouse model.
    Hwang JE; Shim HJ; Park YK; Cho SH; Bae WK; Kim DE; Kim KK; Chung IJ
    J Korean Med Sci; 2011 Nov; 26(11):1439-45. PubMed ID: 22065899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KITENIN recruits Dishevelled/PKC delta to form a functional complex and controls the migration and invasiveness of colorectal cancer cells.
    Kho DH; Bae JA; Lee JH; Cho HJ; Cho SH; Lee JH; Seo YW; Ahn KY; Chung IJ; Kim KK
    Gut; 2009 Apr; 58(4):509-19. PubMed ID: 18653728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KITENIN increases invasion and migration of mouse squamous cancer cells and promotes pulmonary metastasis in a mouse squamous tumor model.
    Lee JK; Bae JA; Sun EG; Kim HD; Yoon TM; Kim K; Lee JH; Lim SC; Kim KK
    FEBS Lett; 2009 Feb; 583(4):711-7. PubMed ID: 19166844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.
    Bae JA; Kho DH; Sun EG; Ko YS; Yoon S; Lee KH; Ahn KY; Lee JH; Joo YE; Chung IJ; Lee SH; Kim H; Kim KK
    Clin Cancer Res; 2016 Mar; 22(5):1284-94. PubMed ID: 26527747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for head and neck squamous cell carcinoma using KITENIN (KAI1 COOH-Terminal Interacting Tetraspanin)-antisense therapy.
    Lee JK; Lee DH; Sun EG; Bae JA; Lim SC; Min JJ; Sung MW; Kim KK
    Yonsei Med J; 2011 May; 52(3):463-8. PubMed ID: 21488189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of Kangai 1 C-terminal interacting tetraspanin suppresses progression of cholangiocarcinoma.
    Bui KC; Barat S; Chen X; Bozko P; Scholta T; Nguyen MLT; Bhuria V; Xing J; Nguyen LT; Le HS; Velavan TP; Sipos B; Wilkens L; Malek NP; Plentz RR
    Exp Cell Res; 2018 Mar; 364(1):59-67. PubMed ID: 29366806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
    Lee JH; Cho ES; Kim MY; Seo YW; Kho DH; Chung IJ; Kook H; Kim NS; Ahn KY; Kim KK
    Cancer Res; 2005 Oct; 65(19):8993-9003. PubMed ID: 16204073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of KITENIN and its association with tumor progression in oral squamous cell carcinoma.
    Yoon TM; Kim SA; Lee JK; Park YL; Kim GY; Joo YE; Lee JH; Kim KK; Lim SC
    Auris Nasus Larynx; 2013 Apr; 40(2):222-6. PubMed ID: 22840317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
    Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS
    Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYO10 contributes to the malignant phenotypes of colorectal cancer via RACK1 by activating integrin/Src/FAK signaling.
    Ou H; Wang L; Xi Z; Shen H; Jiang Y; Zhou F; Liu Y; Zhou Y
    Cancer Sci; 2022 Nov; 113(11):3838-3851. PubMed ID: 35912545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KAI1 COOH-terminal interacting tetraspanin (KITENIN) expression in early and advanced laryngeal cancer.
    Lee JK; Yoon TM; Seo DJ; Sun EG; Bae JA; Lim SC; Choi YD; Lee JH; Joo YE; Kim KK
    Laryngoscope; 2010 May; 120(5):953-8. PubMed ID: 20422689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.